Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension - Talamonti, M.; Teoli, M.; Botti, E.; Spallone, G.; Chimenti, S.; Costanzo, A (Dermatology, 2011)